• 2511 Citations
  • 23 h-Index
19962019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Marlyn J Mayo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Biliary Liver Cirrhosis Medicine & Life Sciences
Ursodeoxycholic Acid Medicine & Life Sciences
Cholangitis Medicine & Life Sciences
Monozygotic Twins Medicine & Life Sciences
Autoimmune Hepatitis Medicine & Life Sciences
Liver Medicine & Life Sciences
Fibrosis Medicine & Life Sciences
Liver Diseases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

  • 2511 Citations
  • 23 h-Index
  • 47 Article
  • 2 Chapter
4 Citations (Scopus)
Ursodeoxycholic Acid
Cholangitis
Transplants
Survival
Therapeutics
1 Citation (Scopus)

Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

the GLOBAL PBC Study Group, Nov 1 2019, In : Alimentary Pharmacology and Therapeutics. 50, 10, p. 1127-1136 10 p.

Research output: Contribution to journalArticle

Open Access
Cholangitis
Fibrosis
Therapeutics
Survival
Patient Advocacy
8 Citations (Scopus)

Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis

Harms, M. H., van Buuren, H. R., Corpechot, C., Thorburn, D., Janssen, H. L. A., Lindor, K. D., Hirschfield, G. M., Parés, A., Floreani, A., Mayo, M. J., Invernizzi, P., Battezzati, P. M., Nevens, F., Ponsioen, C. Y., Mason, A. L., Kowdley, K. V., Lammers, W. J., Hansen, B. E. & van der Meer, A. J., Jan 1 2019, In : Journal of Hepatology.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Cholangitis
Transplants
Survival
Liver
13 Citations (Scopus)

Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial

Hirschfield, G. M., Chazouillères, O., Drenth, J. P., Thorburn, D., Harrison, S. A., Landis, C. S., Mayo, M. J., Muir, A. J., Trotter, J. F., Leeming, D. J., Karsdal, M. A., Jaros, M. J., Ling, L., Kim, K. H., Rossi, S. J., Somaratne, R. M., DePaoli, A. M. & Beuers, U., Jan 1 2018, (Accepted/In press) In : Journal of Hepatology.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Placebos
Alkaline Phosphatase
Bile Acids and Salts
Fibrosis
20 Citations (Scopus)

Major hepatic complications in ursodeoxycholic acid-treated patients with primary biliary cholangitis: Risk factors and time trends in incidence and outcome

Harms, M. H., Lammers, W. J., Thorburn, D., Corpechot, C., Invernizzi, P., Janssen, H. L. A., Battezzati, P. M., Nevens, F., Lindor, K. D., Floreani, A., Ponsioen, C. Y., Mayo, M. J., Dalekos, G. N., Bruns, T., Parés, A., Mason, A. L., Verhelst, X., Kowdley, K. V., Goet, J. C., Hirschfield, G. M. & 2 others, Hansen, B. E. & Van Buuren, H. R., Feb 1 2018, In : American Journal of Gastroenterology. 113, 2, p. 254-264 11 p.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Cholangitis
Liver
Incidence
Fibrosis